{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:39:25Z","timestamp":1784173165098,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,1,26]]},"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>While myeloma is an incurable malignancy, developments in disease management have led to increased life expectancy in recent years. Treatment typically involves stem-cell transplantation. Increased survival rates equate to more patients living with the burden of both the disease and its treatment for increasing number of years, rendering myeloma a long-term condition.<\/jats:p>\n                    <jats:p>Evidence exists to demonstrate the benefits of exercise for patients recovering from stem-cell transplantation, and prehabilitation\u2014exercise before treatment\u2014has been shown to be effective in other disease areas. To date there has been no research into prehabilitation in patients with myeloma awaiting transplantation treatment.<\/jats:p>\n                    <jats:p>Our objective is to determine whether it is feasible to conduct a randomised controlled trial into pretransplant exercise for patients with multiple myeloma who are awaiting autologous stem-cell transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This mixed methods study identifies patients with diagnosis of multiple myeloma who have been assigned to the autologous transplantation list and invites them to participate in six weekly sessions of individualised, supervised exercise while awaiting transplantation.<\/jats:p>\n                    <jats:p>Quantitative data to determine feasibility targets include rates of recruitment, adherence and adverse events, and outcome measures including 6 min walking distance test and quality of life.<\/jats:p>\n                    <jats:p>Qualitative interviews are undertaken with a purposive sample of patients to capture their experiences of the study and the intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics committee approval has been obtained. Dissemination will be through open-access publications and presentations and will seek to reach multiprofessional bases as well as patients and carer groups, addressing the widespread interest in this area of research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT03135925\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\">NCT03135925<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-021333","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T02:25:28Z","timestamp":1520648728000},"page":"e021333","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct03135925","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-1235","authenticated-orcid":false,"given":"Carol","family":"Keen","sequence":"first","affiliation":[{"name":"Acute Therapy Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Skilbeck","sequence":"additional","affiliation":[{"name":"Department of Nursing, Sheffield Hallam University, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ross","sequence":"additional","affiliation":[{"name":"Acute Therapy Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Smith","sequence":"additional","affiliation":[{"name":"Acute Therapy Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Nursing, Sheffield Hallam University, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Dixey","sequence":"additional","affiliation":[{"name":"Acute Therapy Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Walters","sequence":"additional","affiliation":[{"name":"ScHARR, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Greenfield","sequence":"additional","affiliation":[{"name":"Acute Therapy Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"ScHARR, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Snowden","sequence":"additional","affiliation":[{"name":"Acute Therapy Services, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"ScHARR, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mawson","sequence":"additional","affiliation":[{"name":"ScHARR, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"2025121601234708000_8.3.e021333.1","unstructured":"Hameatological Malignancy Research Network. Myeloma Statistics. Statistics on Individual Disorders. https:\/\/www.hmrn.org\/statistics\/disorders\/24."},{"key":"2025121601234708000_8.3.e021333.2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Haemato-cncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum: Guidelines for the Diagnosis and Management of Multiple Myeloma","volume":"154","author":"Bird","year":"2011","journal-title":"Br Jouenal Haematol"},{"key":"2025121601234708000_8.3.e021333.3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2407-10-74","article-title":"Trends in the incidence and survival of multiple myeloma in South East England 1985-2004","volume":"10","author":"Renshaw","year":"2010","journal-title":"BMC Cancer"},{"key":"2025121601234708000_8.3.e021333.4","unstructured":"Cancer Research UK. Myeloma statistics about cancer. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/myeloma."},{"key":"2025121601234708000_8.3.e021333.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"2025121601234708000_8.3.e021333.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08574.x"},{"key":"2025121601234708000_8.3.e021333.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08573.x"},{"key":"2025121601234708000_8.3.e021333.8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12926"},{"key":"2025121601234708000_8.3.e021333.9","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3026(16)30049-7","article-title":"The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT\/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial","volume":"3","author":"Cook","year":"2016","journal-title":"Lancet Haematol"},{"key":"2025121601234708000_8.3.e021333.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70245-1"},{"key":"2025121601234708000_8.3.e021333.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.11.003"},{"key":"2025121601234708000_8.3.e021333.12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjh.14514","article-title":"Guidelines for screening and management of late and long-term consequences of myeloma and its treatment","volume":"176","author":"Snowden","year":"2017","journal-title":"Br J Haematol"},{"key":"2025121601234708000_8.3.e021333.13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-319"},{"key":"2025121601234708000_8.3.e021333.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009576","article-title":"Multiple myeloma and physical activity: a scoping review","volume":"5","author":"Smith","year":"2015","journal-title":"BMJ Open"},{"key":"2025121601234708000_8.3.e021333.15","unstructured":"Hoffman R , Mooney K , Barton D , et al . Exercise and stem cell transplantation. 2013."},{"key":"2025121601234708000_8.3.e021333.16","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-671","article-title":"Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in p","volume":"10","author":"Persoon","year":"2010","journal-title":"BMC Cancer"},{"key":"2025121601234708000_8.3.e021333.17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-31","article-title":"A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors","volume":"13","author":"Groeneveldt","year":"2013","journal-title":"BMC Cancer"},{"key":"2025121601234708000_8.3.e021333.18","first-page":"473","article-title":"A journey to make cancer rehabilitation the standard of care","volume":"46","author":"Silver","year":"2013","journal-title":"Work"},{"key":"2025121601234708000_8.3.e021333.19","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e31829b4afe"},{"key":"2025121601234708000_8.3.e021333.20","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318295fef8"},{"key":"2025121601234708000_8.3.e021333.21","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-200310000-00012"},{"key":"2025121601234708000_8.3.e021333.22","unstructured":"Cook G , Williams C , Szubert A , et al . A second autologous stem cell transplant induces superior response durability following bortezomib-containing reinduction therapy for relapsed multiple myeloma: results from the BSBMT\/UKMF myeloma x (intensive) trial: O155.. Bone Marrow Transplant 2013;48(S17)."},{"key":"2025121601234708000_8.3.e021333.23","first-page":"783","article-title":"The six-minute walk test","volume":"48","author":"Enright","year":"2003","journal-title":"Respir Care"},{"key":"2025121601234708000_8.3.e021333.24","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323746"},{"key":"2025121601234708000_8.3.e021333.25","unstructured":"Ritchie J , Lewis J . Qualitative research practice. London: Sage, 2003."},{"key":"2025121601234708000_8.3.e021333.26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7748\/nr2013.03.20.4.6.e291","article-title":"How case-study research can help to explain implementation of the nurse practitioner role","volume":"20","author":"Sangster-Gormley","year":"2013","journal-title":"Nurse Res"},{"key":"2025121601234708000_8.3.e021333.27","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5868-4-34"},{"key":"2025121601234708000_8.3.e021333.28","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-63"},{"key":"2025121601234708000_8.3.e021333.29","unstructured":"European Organisation for Research and Treatment of Cancer. EORTC Quality of life Questionnaire. Quality of Life. http:\/\/groups.eortc.be\/qol\/eortc-qlq-c30."},{"key":"2025121601234708000_8.3.e021333.30","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpainsymman.2011.06.019","article-title":"Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction","volume":"43","author":"Wagner","year":"2012","journal-title":"J Pain Symptom Manage"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-021333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:23:58Z","timestamp":1765877038000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-021333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,9]]},"published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1136\/bmjopen-2017-021333"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-021333","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}